Breaking News Instant updates and real-time market news.

TLRY

Tilray

$80.75

1.08 (1.36%)

07:02
01/11/19
01/11
07:02
01/11/19
07:02

Privateer Holdings does not plan to register, sell Tilray shares in 1H19

Privateer Holdings issued the following statement, strongly emphasizing that it does not have plans to register, sell or distribute the 75M shares that Privateer owns in Tilray when the lock-up expires next week. Statement from Michael Blue, Managing Partner of Privateer Holdings, in response to market speculation regarding its Tilray shareholding: "Privateer Holdings strongly believes in Tilray's long-term global growth strategy and pioneering role in shaping the future of the legal cannabis industry. Given this, we do not have plans to register, sell or distribute the shares Privateer holds in Tilray during the first half of 2019. When we decide to distribute shares, we will do so in an orderly and deliberate manner to maximize tax-efficiency considerations for Privateer investors, while also taking into consideration potential impacts on Tilray's public float. And we will do it in a way that reflects our long-term confidence in Tilray's business model and management team."

  • 14

    Jan

TLRY Tilray
$80.75

1.08 (1.36%)

11/14/18
BNCH
11/14/18
NO CHANGE
Target $200
BNCH
Buy
Tilray reported 'strong' Q3 sales without recreational cannabis, says Benchmark
Benchmark analyst Mike Hickey said Tilray reported "strong" Q3 sales even though the company did not recognize sales from recreational cannabis use in the quarter. Recreational use experienced a slow start, primarily due to the timing of licenses, distribution and retail infrastructure, as expected, said Hickey, who adds that there "appears to be exceedingly strong demand" from Canadians. He has raised his Q4 sales forecast based on increased production and presumed ongoing strong consumer demand and keeps a Buy rating on Tilray with a $200 price target.
12/18/18
COWN
12/18/18
NO CHANGE
COWN
Outperform
Cowen sees Sandoz deal as reinforcing Tilray's competitive positioning
Tilray's (TLRY) expanded global partnership with Novartis (NVS) division Sandoz can not only help expand its reach with pharmacists, physicians and distributors, it can also help Tilray capture early share in new medical cannabis markets as they come online, Cowen analyst Vivien Azer tells investors in a research note. Further, the analyst believes the partnership also helps legitimize cannabis in international markets, which could help influence countries considering medical cannabis legalization. Azer estimates international will represent 15% of Tilray's revenue in fiscal 2020 and 22% in fiscal 2021. Not only does the deal allow Tilray to expand geographic reach, but also to grow at scale, says Azer. And most notably, the Sandoz deal reinforces Tilray's competitive positioning, adds the analyst, who keeps an Outperform rating on the shares with a $150 price target. The stock in morning trading is up 9%, or $5.98, to $71.87.
01/09/19
PIPR
01/09/19
INITIATION
Target $90
PIPR
Overweight
Tilray initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery initiated coverage of Tilray with an Overweight rating and $90 price target. The analyst expects "strong" industry growth long-term, and believes Tilray is well positioned to be one of several likely winners given its relationships in medical, in the U.S., and in beverages. Lavery consider the company's initial public offering lock-up expiry to be a near-term risk, especially with 77% insider ownership, but his 12-month Overweight view is based on its fundamental outlook. He pegs Tilray's market opportunity at $15B-$50B in the near-term, and potentially $250B-$500B over the longer term.
01/09/19
PIPR
01/09/19
INITIATION
PIPR
Overweight
Piper Jaffray rolls out bullish research coverage on Canopy Growth, Tilray
Piper Jaffray analyst Michael Lavery initiated coverage of Canopy Growth (CGC) and Tilray (TLRY) with Overweight ratings and price targets of $40 and $90, respectively. The analyst believes the global Cannabis market has the potential to reach $250B-$500B over the long term and $15B-$50B in the near term. The industry's long-term growth opportunities are significant, both from transitioning illicit trade to legal sales and from transitioning sales in health and wellness categories to cannabidiol-infused products, Lavery tells investors in a research note. The analyst expects recreational use to source from illicit trade and alcohol, medical use to source from other medical treatments, and non-psychoactive CBD-infused cannabis products to source users from food, beverage, and personal care categories. Over 25 countries have legal marijuana use today, he points out. Lavery believes federal legalization in the U.S. could potentially come in the next five years. Further, the analyst expects capital flow into the sector will likely continue.

TODAY'S FREE FLY STORIES

MAS

Masco

$31.00

-1.21 (-3.76%)

07:13
01/23/19
01/23
07:13
01/23/19
07:13
Initiation
Masco initiated  »

Masco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

HII

Huntington Ingalls

$196.46

-3.82 (-1.91%)

07:13
01/23/19
01/23
07:13
01/23/19
07:13
Downgrade
Huntington Ingalls rating change  »

Barclays double…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:12
01/23/19
01/23
07:12
01/23/19
07:12
Hot Stocks
Breaking Hot Stocks news story on Comcast »

Comcast up 3.6% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:11
01/23/19
01/23
07:11
01/23/19
07:11
Hot Stocks
Comcast raises annualized dividend by 10% to 84c per share »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

MTG

MGIC Investment

$11.63

-0.15 (-1.27%)

07:10
01/23/19
01/23
07:10
01/23/19
07:10
Hot Stocks
MGIC Investment announces executive promotions »

MGIC Investment's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

UTX

United Technologies

$111.23

-2.7 (-2.37%)

07:10
01/23/19
01/23
07:10
01/23/19
07:10
Hot Stocks
United Technologies up over 4.5% after Q4 earnings beat, initial FY19 guidance »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Hot Stocks
Comcast reports Q4 pro-forma revenue for Sky up 2.4% to $5B »

Pro Forma Revenue for Sky…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CPA

Copa Holdings

$88.31

-3.84 (-4.17%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Upgrade
Copa Holdings rating change  »

Copa Holdings upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Hot Stocks
Comcast reports Q4 NBCUniversal revenue $9.4B vs. $8.77B last year »

Revenue for NBCUniversal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

WSM

Williams-Sonoma

$52.51

-1.26 (-2.34%)

07:09
01/23/19
01/23
07:09
01/23/19
07:09
Downgrade
Williams-Sonoma rating change  »

Morgan Stanley downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$128.76

-1.89 (-1.45%)

07:08
01/23/19
01/23
07:08
01/23/19
07:08
Periodicals
Johnson & Johnson pursuing acquisition of Auris Health, Bloomberg reports »

Johnson & Johnson is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 18

    Feb

CMCO

Columbus McKinnon

$33.82

-0.39 (-1.14%)

07:08
01/23/19
01/23
07:08
01/23/19
07:08
Initiation
Columbus McKinnon initiated  »

Columbus McKinnon resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

MTBC

Medical Transcription Billing

$4.36

-0.12 (-2.68%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Recommendations
Medical Transcription Billing analyst commentary  »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$90.50

-0.89 (-0.97%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Earnings
Procter & Gamble reaffirms FY19 core EPS growth of 3%-8% vs. FY18 »

Consensus $4.42. "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

  • 03

    Mar

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:07
01/23/19
01/23
07:07
01/23/19
07:07
Hot Stocks
Comcast reports Q4 high-speed internet customer net additions 351,000 »

Total Customer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

07:07
01/23/19
01/23
07:07
01/23/19
07:07
General news
MBA Mortgage Applications Composite Index data reported »

Week of 1/18 MBA Mortgage…

GSBC

Great Southern Bancorp

$49.85

-0.7 (-1.38%)

07:05
01/23/19
01/23
07:05
01/23/19
07:05
Hot Stocks
Great Southern Bancorp declares 75c per share special cash dividend »

The board of Great…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 13

    Feb

  • 14

    Feb

SJW

SJW Corp.

$58.22

-0.16 (-0.27%)

, CTWS

Connecticut Water

$65.10

-0.62 (-0.94%)

07:05
01/23/19
01/23
07:05
01/23/19
07:05
Hot Stocks
Connecticut Water withdraws Maine Water application before SJW Corp. merger »

SJW Group (SJW) and…

SJW

SJW Corp.

$58.22

-0.16 (-0.27%)

CTWS

Connecticut Water

$65.10

-0.62 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UQM

UQM Technologies

$1.65

0.55 (50.00%)

07:04
01/23/19
01/23
07:04
01/23/19
07:04
Downgrade
UQM Technologies rating change  »

UQM Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADDYY

Adidas

$0.00

(0.00%)

07:04
01/23/19
01/23
07:04
01/23/19
07:04
Periodicals
Adidas CEO says biggest concern is Brexit impact, CNBC reports »

Speaking from Davos with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$163.53

-1.58 (-0.96%)

, NOC

Northrop Grumman

$264.70

-2.84 (-1.06%)

07:04
01/23/19
01/23
07:04
01/23/19
07:04
Hot Stocks
Raytheon to maintain, cybersecure U.S. Air Force Global Hawk ground control »

Raytheon (RTN) will…

RTN

Raytheon

$163.53

-1.58 (-0.96%)

NOC

Northrop Grumman

$264.70

-2.84 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 31

    Jan

BHBK

Blue Hills Bancorp

$23.07

0.22 (0.96%)

07:04
01/23/19
01/23
07:04
01/23/19
07:04
Earnings
Blue Hills Bancorp reports Q4 EPS 28c, consensus 28c »

Reports Q4 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$35.16

-1.05 (-2.90%)

07:03
01/23/19
01/23
07:03
01/23/19
07:03
Earnings
Comcast reports Q4 adj. EPS 64c, consensus 62c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SVMK

SurveyMonkey

$12.70

-0.66 (-4.94%)

, FB

Facebook

$147.80

-2.21 (-1.47%)

07:03
01/23/19
01/23
07:03
01/23/19
07:03
Hot Stocks
SurveyMonkey hires Google and Facebook alum Joe Cummiskey »

SurveyMonkey (SVMK)…

SVMK

SurveyMonkey

$12.70

-0.66 (-4.94%)

FB

Facebook

$147.80

-2.21 (-1.47%)

GOOG

Alphabet

$1,070.72

-27.53 (-2.51%)

GOOGL

Alphabet Class A

$1,078.68

-28.24 (-2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 30

    Jan

  • 04

    Feb

  • 04

    Feb

  • 25

    Feb

  • 03

    Mar

PG

Procter & Gamble

$90.50

-0.89 (-0.97%)

07:02
01/23/19
01/23
07:02
01/23/19
07:02
Earnings
Procter & Gamble reports Q2 core EPS $1.25, consensus $1.21 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 18

    Feb

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.